{"title": "\u00bfLa cura del herpes? Hay avances que reportar", "author": "Sabin Russell", "url": "https://www.fredhutch.org/en/news/center-news/2020/08/herpes-simple-terapia-genica.html", "hostname": "fredhutch.org", "description": "Las t\u00e9cnicas mejoradas de terapia g\u00e9nica eliminan hasta el 95% del virus del herpes, inactivo en ratones. \u00bfHabr\u00e1 estudios cl\u00ednicos con personas? Faltan por lo menos tres a\u00f1os. El Dr. Keith Jerome espera que esta investigaci\u00f3n nos motive a pensar en la posibilidad de la cura del virus.", "sitename": "Fred Hutch", "date": "2020-08-18", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "This story was originally\n[published in English in August 2020](/en/news/center-news/2020/08/herpes-simplex-gene-therapy.html).\nPara detener a un virus persistente, se necesita a una cient\u00edfica persistente.\nHace diez a\u00f1os, el vir\u00f3logo\n[Dr. Keith Jerome](/en/faculty-lab-directory/jerome-keith.html) del Centro de Investigaci\u00f3n del C\u00e1ncer Fred Hutchinson, comenz\u00f3 a explorar la idea de que las infecciones por los virus del herpes, que duran toda la vida, podr\u00edan curarse con las herramientas de corte de ADN de la terapia g\u00e9nica.\nLa investigaci\u00f3n inicial mostr\u00f3 que estas t\u00e9cnicas pod\u00edan eliminar peque\u00f1as cantidades de virus inactivo, y el trabajo de mejorar los resultados recay\u00f3 en la jefa de investigaci\u00f3n cient\u00edfica del laboratorio del Dr. Jerome, la\n[Dra. Martine Aubert](/en/research/divisions/vaccine-infectious-disease-division/faculty-labs/vidd-staff-scientists-physicians/aubert-martine.html). Hace cinco a\u00f1os, el equipo inform\u00f3 que hab\u00edan [da\u00f1ado los genes del 2% al 4%](/en/news/center-news/2016/09/can-gene-editing-cure-herpes.html) del virus del herpes en ratones infectados. El trabajo de la Dra. Aubert demostr\u00f3 que la t\u00e9cnica pod\u00eda ser viable, pero estaba muy lejos de ser una cura.\nSin embargo, ella persisti\u00f3.\nEl 18 de agosto, el equipo dirigido por el Dr. Jerome y la Dra. Aubert public\u00f3 un art\u00edculo en la revista cient\u00edfica\n[Nature Communications](http://dx.doi.org/10.1038/s41467-020-17936-5) en el que mostr\u00f3 que, despu\u00e9s de varias mejoras graduales en su m\u00e9todo original, hab\u00edan destruido hasta 95% del virus del herpes, que se ocultaba en ciertos grupos de c\u00e9lulas nerviosas de ratones.\n\"Esta es la primera vez que alguien ha podido entrar y en s\u00ed eliminar la mayor\u00eda del herpes en un cuerpo\", dijo el Dr. Jerome, quien tambi\u00e9n encabeza investigaciones cient\u00edficas sobre COVID-19 en Fred Hutch y la Universidad de Washington. \"Es un enfoque de la terapia contra el herpes completamente distinto al que se hab\u00eda tenido hasta ahora\".\n\u2014 Dr. Keith Jerome, el Centro de Investigaci\u00f3n del C\u00e1ncer Fred Hutchinson\nEl virus del herpes oculto se desactiva con una inyecci\u00f3n que encuentra a las c\u00e9lulas nerviosas infectadas y hace que elaboren enzimas especiales para cortar genes. Estas enzimas, funcionan como tijeras moleculares para cortar genes del virus del herpes en lugares espec\u00edficos. Gran parte del esfuerzo detallado del equipo cient\u00edfico en los \u00faltimos cinco a\u00f1os se ha centrado en encontrar mejores formas de dirigirse a los grupos de c\u00e9lulas nerviosas infectadas e impedir la habilidad del virus para reparar de manera r\u00e1pida los cortes a sus genes.\nMientras que la mayor\u00eda de las investigaciones sobre el herpes se han enfocado en inhibir la recurrencia (regreso) de s\u00edntomas dolorosos, el trabajo de la terapia g\u00e9nica de Fred Hutch aborda la causa principal de la reactivaci\u00f3n: la presencia de virus inactivos en las c\u00e9lulas nerviosas infectadas.\n\"Espero que este estudio cambie el di\u00e1logo sobre la investigaci\u00f3n del herpes y nos motive a pensar en la cura, en lugar de solo en el control del virus\", dijo el Dr. Jerome.\nTodav\u00eda falta mucho para que estos experimentos resulten en los primeros estudios cl\u00ednicos de terapia g\u00e9nica para curar el herpes en los que participen personas. El Dr. Jerome calcula que ser\u00e1n al menos tres a\u00f1os.\nEl virus del herpes simple afecta a miles de millones de personas en todo el mundo. Seg\u00fan la\n[Organizaci\u00f3n Mundial de la Salud](https://www.who.int/es/news-room/fact-sheets/detail/herpes-simplex-virus), dos terceras partes de la poblaci\u00f3n mundial menor de 50 a\u00f1os son portadoras del virus de herpes simple tipo 1, o HSV-1, que causa principalmente el herpes labial. Tambi\u00e9n, 491 millones de personas de entre 15 y 49 a\u00f1os est\u00e1n infectadas con un virus de la misma familia, el HSV-2, que causa el herpes genital por transmisi\u00f3n sexual.\nAunque el f\u00e1rmaco antiviral\n[aciclovir](https://medlineplus.gov/spanish/druginfo/meds/a681045-es.html) puede acabar con un brote de HSV-2, el virus perdura de por vida dentro de las c\u00e9lulas nerviosas infectadas y puede reactivarse. Esto provoca periodos repetidos con llagas dolorosas, en promedio, de dos a siete veces al a\u00f1o. Esta enfermedad a largo plazo es m\u00e1s com\u00fan en personas de mayor edad. Menos del 1% de las personas adolescentes en Estados Unidos est\u00e1n infectadas, pero el n\u00famero de infecciones aumenta al 21% de las personas de 40 a\u00f1os en adelante, seg\u00fan los [Centros para el Control y la Prevenci\u00f3n de Enfermedades](https://www.cdc.gov/nchs/products/databriefs/db304.htm) (CDC). La infecci\u00f3n por HSV-2, no solo complica la vida sexual de las parejas, tambi\u00e9n aumenta la susceptibilidad de una persona al VIH, el virus que causa el SIDA.\nLa investigaci\u00f3n sobre el herpes en el laboratorio que encabeza el Dr. Jerome hasta ahora es solo con HSV-1, pero el equipo cient\u00edfico est\u00e1 trabajando en formas de aplicar su \u00e9xito al HSV-2. El primer paso ser\u00e1 repetir sus experimentos con HSV-2 en conejillos de indias. A diferencia de los ratones, los conejillos de indias sufren reactivaciones naturales de infecciones con el virus del herpes, al igual que los seres humanos\nMuchos de los avances en la investigaci\u00f3n de la cura del herpes de los \u00faltimos cinco a\u00f1os se deben a las mejoras en las herramientas de edici\u00f3n de genes. Primero, el equipo de investigaci\u00f3n agreg\u00f3 conjuntos de distintas enzimas para el corte de genes. Entre m\u00e1s cortes hagan estas tijeras moleculares, es m\u00e1s dif\u00edcil que el virus se recupere.\nEn segundo lugar, eligieron distintas cepas de virus inofensivos, transportadores de enzimas. Estos virus transportan mejor las herramientas para cortar ADN a los lugares del cuerpo donde se agrupan las c\u00e9lulas nerviosas infectadas.\n\u201cHan sido tres o cuatro a\u00f1os de trabajo, pero creo que la descripci\u00f3n que hicimos en el art\u00edculo es un gran paso\u201d, dijo la Dra. Aubert. \u201cNos acerca a considerarlo realmente como un enfoque curativo. Nos da la luz verde\".\nDesde los primeros d\u00edas de los experimentos, el equipo del Dr. Jerome aprendi\u00f3 a utilizar una enzima de corte, llamada \"meganucleasa\", que puede concentrarse en un segmento de ADN del herpes y cortar ambas hebras de su doble h\u00e9lice. A pesar del \"mega\" en su nombre, esta enzima tijera es exageradamente peque\u00f1a, mide alrededor de la mitad de un anticuerpo: un tipo de prote\u00edna peque\u00f1a en forma de Y que nuestro sistema inmunitario usa para invadir y desactivar virus y bacterias.\nEl equipo logr\u00f3 sus primeros resultados prometedores hace a\u00f1os utilizando un solo tipo de meganucleasa, que result\u00f3 eficaz para cortar el ADN del virus del herpes, pero los resultados fueron de corta duraci\u00f3n. El virus casi siempre pod\u00eda aprovechar los programas de reparaci\u00f3n del ADN de las propias c\u00e9lulas infectadas para reparar la rotura de su ADN. Esto suced\u00eda debido a que los programas de reparaci\u00f3n de ADN de las c\u00e9lulas infectadas no distinguen entre los genes del virus y los suyos.\nPero con el tiempo, el equipo de investigaci\u00f3n descubri\u00f3 que pod\u00edan eliminar hasta el 90% del virus inactivo si combinaban dos o tres meganucleasas diferentes. Es simplemente m\u00e1s dif\u00edcil reparar dos roturas que una. Con m\u00e1s ajustes, los resultados siguieron mejorando.\nEl equipo de investigaci\u00f3n tambi\u00e9n perfeccion\u00f3 sus m\u00e9todos para transportar las tijeras moleculares a c\u00e9lulas nerviosas espec\u00edficas. Desde el principio, el Dr. Jerome y sus colegas aprovecharon un virus hueco e inofensivo que se dirige a las prote\u00ednas en la superficie de las c\u00e9lulas nerviosas. Se le llama vector de virus adeno-asociado, o AAV (por sus siglas en ingl\u00e9s) y es el caballo de fuerza de la terapia g\u00e9nica. En este caso, se utiliza para transportar instrucciones gen\u00e9ticas a las c\u00e9lulas nerviosas infectadas. Lo anterior hace que las c\u00e9lulas nerviosas elaboren las meganucleasas.\n\u201cInyectamos el vector AAV y \u00e9l encuentra su camino\u201d, dijo la Dra. Aubert.\nEl virus del herpes inactivo se oculta en agrupaciones de c\u00e9lulas nerviosas llamadas ganglios, y el equipo de investigaci\u00f3n observ\u00f3 que algunos ganglios son m\u00e1s dif\u00edciles de alcanzar que otros. Con el paso de los a\u00f1os, descubrieron que algunas cepas de AAV son mejores que otras para encontrar ciertos tipos de grupos de nervios, y esto les ha ayudado a ajustar la selecci\u00f3n de los virus de transporte, para que lleguen a las c\u00e9lulas infectadas en distintos lugares.\nEn sus experimentos con ratones, el equipo sigui\u00f3 mejorando sus resultados poco a poco, hasta reducir el 95% de la infecci\u00f3n por el virus del herpes en un grupo visible de nervios. Utilizaron tres tipos de AAV diferentes, que transportaron una selecci\u00f3n de dos meganucleasas distintas. El equipo espera seguir mejorando su capacidad para erradicar el virus, al seleccionar vectores que est\u00e9n preparados para llegar a grupos de nervios m\u00e1s dif\u00edciles de alcanzar.\nMientras el equipo de Jerome Lab (laboratorio Jerome) se prepara para averiguar si su terapia g\u00e9nica puede bloquear el herpes genital, tambi\u00e9n est\u00e1n reorganizando su selecci\u00f3n de virus vectores y meganucleasas, para dirigirlas a las c\u00e9lulas nerviosas infectadas por HSV-2. Est\u00e1n colaborando con el\n[Dr. Barry Stoddard](/en/faculty-lab-directory/stoddard-barry.html), un colega de Fred Hutch que se especializa en descubrir la estructura de las prote\u00ednas, para dise\u00f1ar un conjunto de meganucleasas. Esperan que este conjunto funcione incluso mejor que el primero.\n\u201cLas tres enzimas que usan ya funcionan bastante bien, pero una no funciona tan bien como las otras\u201d, dijo el Dr. Stoddard. \"Estamos analizando la estructura y determinaremos algunos cambios para mejorar su desempe\u00f1o\".\nStoddard tambi\u00e9n har\u00e1 cambios a las estructuras de las meganucleasas para que se ajusten mejor al HSV-2.\nEn su \u00faltimo art\u00edculo, el equipo evalu\u00f3 el uso de la herramienta de corte de genes m\u00e1s nueva y glamorosa, la CRISPR-Cas9. Observaron algo un poco inesperado: que esta nueva herramienta de corte de precisi\u00f3n no funcionaba tan bien como sus meganucleasas. Una raz\u00f3n posible es que CRISPR es una mol\u00e9cula mucho m\u00e1s grande y las meganucleasas, que son muy peque\u00f1as, son m\u00e1s f\u00e1ciles de empacar y entregar a las c\u00e9lulas nerviosas.\nEl Dr. Stoddard dijo que las meganucleasas tambi\u00e9n pueden concentrarse con mayor precisi\u00f3n que CRISPR en sus genes objetivo. A CRISPR se le conoce por sus efectos \"fuera del objetivo\", es decir, porque corta el gen incorrecto. La ventaja de CRISPR es que se puede dise\u00f1ar m\u00e1s r\u00e1pido, mientras que fabricar las meganucleasas requiere m\u00e1s esfuerzo.\n\u201cFabricar un nuevo CRISPR puede llevar un d\u00eda. Se necesitan aproximadamente tres meses para fabricar una meganucleasa\", mencion\u00f3 el Dr. Stoddard.\nSin embargo, los hechos demuestran que al equipo de Jerome Lab le sobra paciencia. Su trayecto de 10 a\u00f1os mostr\u00f3 el potencial de la terapia g\u00e9nica para eliminar el herpes. Sin duda, en el camino que les queda por delante tambi\u00e9n se necesitar\u00e1 mucha paciencia y perseverancia.\nLa Dra. Aubert mencion\u00f3 que, para ella, eso es natural.\n\"A m\u00ed, personalmente, no me gusta dejar las cosas sin terminar. Yo soy as\u00ed\", dijo.\nLa investigaci\u00f3n cont\u00f3 con el apoyo de la Fundaci\u00f3n Caladan y los Institutos Nacionales de Salud. Cellectis SA, con sede en Par\u00eds, proporcion\u00f3 las meganucleasas que se utilizaron en los experimentos del art\u00edculo de Nature Communications mencionado.\nNota: El equipo cient\u00edfico de Fred Hutch particip\u00f3 en el desarrollo de estos descubrimientos, y es posible que Fred Hutch y las personas que integran su equipo cient\u00edfico se beneficien econ\u00f3micamente de este trabajo en el futuro.\nThis story was translated from the original English by Adriana Nodal-Tarafa with editing by Sergio Enciso.\n\u00bfTiene alguna pregunta sobre la investigaci\u00f3n del herpes de Fred Hutch? Consulte nuestra secci\u00f3n especial sobre\n[Herpesvirus](https://www.fredhutch.org/en/research/diseases/herpes.html) o comun\u00edquese en [HSV@fredhutch.org](mailto:HSV@fredhutch.org).\nSabin Russell es escritor de planta de Fred Hutchinson Cancer Center. Cubri\u00f3 las ciencias m\u00e9dicas, la salud global y la econom\u00eda de la atenci\u00f3n de la salud durante dos d\u00e9cadas para San Francisco Chronicle, y escribi\u00f3 extensamente sobre enfermedades infecciosas, incluido el VIH / SIDA. Fue becario de Knight Science Journalism en el MIT y escritor independiente para el New York Times y Health Affairs.\n\u00bfEst\u00e1 interesado/a en imprimir o publicar este art\u00edculo? \u00a1Se nuestro invitado! Queremos ayudar a conectar personas con la informaci\u00f3n que necesitan. Solo le pedimos que incluya un enlace al art\u00edculo original, conserve la l\u00ednea del autor y se abstenga de realizar modificaciones que alteren el contexto original. \u00bfPreguntas? Env\u00edenos un correo electr\u00f3nico a\n[communications@fredhutch.org](mailto:communications@fredhutch.org).\nEvery dollar counts. Please support lifesaving research today.", "language": null, "image": "https://www.fredhutch.org/content/dam/public/communications/Photo/2020/08-august/200818/social-aubert-jerome.jpg", "pagetype": "article", "links": ["/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/patient-care/for-physicians.html", "/en/about/careers.html", "/en/about/fred-hutch-locations.html", "/en/about/contact-us.html", "/en.html", null, "/en/patient-care.html", "/en/patient-care/patient-services.html", "/en/patient-care/patient-services/insurance-and-billing.html", "/en/patient-care/patient-services/medical-record-request.html", "/en/patient-care/patient-services/pharmacy.html", "/en/patient-care/patient-services/housing.html", "/en/patient-care/patient-services/amenities.html", "/en/patient-care/patient-services/interpreter-services.html", "/en/patient-care/patient-services/telehealth.html", "/en/patient-care/for-caregivers.html", "/en/patient-care/for-caregivers/resources.html", "/en/patient-care/services.html", "/en/patient-care/services/cancer-rehabilitation.html", "/en/patient-care/services/child-life.html", "/en/patient-care/services/integrative-medicine.html", "/en/patient-care/services/nutrition.html", "/en/patient-care/services/oncoreproduction-clinic.html", "/en/patient-care/services/pain-clinic.html", "/en/patient-care/services/palliative-care.html", "/en/patient-care/services/patient-navigators.html", "/en/patient-care/services/physical-therapy.html", "/en/patient-care/services/psychiatry.html", "/en/patient-care/services/sexual-health.html", "/en/patient-care/services/social-work.html", "/en/patient-care/services/spiritual-health.html", "/en/patient-care/services/support-groups.html", "/en/patient-care/services/survivorship.html", "/en/patient-care/treatments.html", "/en/patient-care/treatments/blood-marrow-transplant.html", "/en/patient-care/treatments/immunotherapy.html", "/en/patient-care/treatments/medical-oncology.html", "/en/patient-care/treatments/radiation-oncology.html", "/en/patient-care/treatments/surgical-oncology.html", "/en/patient-care/treatments/proton-therapy.html", "/en/patient-care/treatments/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy.html", "/en/patient-care/prevention.html", "/en/patient-care/prevention/breast-cancer-screening.html", "/en/patient-care/prevention/colorectal-cancer-early-detection.html", "/en/patient-care/prevention/genetic-counseling-clinical-genetics.html", "/en/patient-care/prevention/lung-cancer-early-detection.html", "/en/patient-care/prevention/prostate-cancer-early-detection.html", "/en/patient-care/prevention/womens-wellness.html", "/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/about/fred-hutch-locations.html", "/en/patient-care/covid19.html", "/en/education-training/patient-education.html", "/en/about/contact-us/transportation.html", "/en/about/contact-us.html", null, "/en/diseases.html", "/en/diseases/acute-lymphoblastic-leukemia.html", "/en/diseases/acute-myeloid-leukemia.html", "/en/diseases/adrenal-cancer.html", "/en/diseases/amyloidosis.html", "/en/diseases/anal-cancer.html", "/en/diseases/aplastic-anemia.html", "/en/diseases/autoimmune-diseases.html", "/en/diseases/bladder-cancer.html", "/en/diseases/blood-disorders.html", "/en/diseases/brain-and-spinal-cord-cancers.html", "/en/diseases/breast-cancer.html", "/en/diseases/cervical-cancer.html", "/en/diseases/chronic-lymphocytic-leukemia.html", "/en/diseases/chronic-myeloid-leukemia.html", "/en/diseases/colon-cancer.html", "/en/diseases/cutaneous-lymphoma.html", "/en/diseases/endocrine-tumors.html", "/en/diseases/endometrial-cancer.html", "/en/diseases/esophageal-cancer.html", "/en/diseases/gastrointestinal-cancer.html", "/en/diseases/gynecologic-cancer.html", "/en/diseases/head-and-neck-cancers.html", "/en/diseases/hodgkin-lymphoma.html", "/en/diseases/kidney-cancer.html", "/en/diseases/leukemia.html", "/en/diseases/liver-tumors-cancer.html", "/en/diseases/lung-cancer.html", "/en/diseases/lymphedema.html", "/en/diseases/melanoma.html", "/en/diseases/merkel-cell-carcinoma.html", "/en/diseases/mesothelioma.html", "/en/diseases/multiple-myeloma.html", "/en/diseases/myelodysplastic-syndrome.html", "/en/diseases/myeloproliferative-neoplasms.html", "/en/diseases/neuroendocrine-tumors.html", "/en/diseases/non-hodgkin-lymphoma.html", "/en/diseases/oral-cancer.html", "/en/diseases/ovarian-cancer.html", "/en/diseases/pancreatic-cancer.html", "/en/diseases/parathyroid-cancer.html", "/en/diseases/prostate-cancer.html", "/en/diseases/rectal-cancer.html", "/en/diseases/salivary-gland-cancer.html", "/en/diseases/sarcoma.html", "/en/diseases/sickle-cell-disease.html", "/en/diseases/skin-cancer.html", "/en/diseases/stomach-cancer.html", "/en/diseases/testicular-cancer.html", "/en/diseases/thyroid-cancer.html", "/en/diseases/uterine-sarcoma.html", "/en/diseases/vulvar-cancer.html", "/en/diseases/waldenstrom-macroglobulinemia.html", null, "/en/research.html", "/en/research/research-areas.html", "/en/research/research-areas/behavioral-research.html", "/en/research/research-areas/biostatistics.html", "/en/research/research-areas/cell-gene-therapy.html", "/en/research/research-areas/cell-biology.html", "/en/research/research-areas/data-science.html", "/en/research/research-areas/diagnostics-biomarkers.html", "/en/research/research-areas/disease-prevention.html", "/en/research/research-areas/epidemiology.html", "/en/research/research-areas/gene-regulation-expression.html", "/en/research/research-areas/genetics-and-genomics.html", "/en/research/research-areas/global-health.html", "/en/research/research-areas/health-economics.html", "/en/research/research-areas/hematopoietic-transplantation.html", "/en/research/research-areas/immunotherapy.html", "/en/research/research-areas/infectious-diseases.html", "/en/research/research-areas/microbiome.html", "/en/research/research-areas/survivorship.html", "/en/research/research-areas/vaccine-development.html", "/en/research/research-areas/virology.html", "/en/research/diseases.html", "/en/research/diseases/autoimmune-diseases.html", "/en/research/diseases/cancers.html", "/en/research/diseases/coronavirus.html", "/en/research/diseases/genetic-disorders.html", "/en/research/diseases/herpes.html", "/en/research/diseases/hiv-aids.html", "/en/research/divisions.html", "/en/research/divisions/basic-sciences-division.html", "/en/research/divisions/clinical-research-division.html", "/en/research/divisions/human-biology-division.html", "/en/research/divisions/public-health-sciences-division.html", "/en/research/divisions/vaccine-infectious-disease-division.html", "/en/research/clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials/health-insurance.html", "/en/research/clinical-trials/guide-clinical-trials/deciding-to-participate.html", "/en/research/covid-19-clinical-research-center.html", "/en/research/patient-treatment-support/long-term-follow-up.html", "/en/research/patient-treatment-support/survivorship-program.html", "https://www.cookforyourlife.org/", "/en/faculty-lab-directory.html", "/en/education-training.html", "/en/research/institutes-networks-ircs.html", "/en/research/institutes-networks-ircs/ocoe.html", "/en/projects.html", "/en/research/scientific-publications.html", "/en/research/shared-resources.html", "/en/investors.html", null, "/en/education-training.html", "/en/education-training/patient-education.html", "/en/education-training/patient-education/resource-center.html", "/en/education-training/patient-education/courses.html", "/en/education-training/patient-education/videos.html", "/en/education-training/health-care-professionals.html", "/en/education-training/health-care-professionals/provider-professional-development.html", "/en/education-training/health-care-professionals/nursing-professional-development.html", "/en/education-training/teachers-students.html", "/en/education-training/teachers-students/science-education-partnership.html", "/en/education-training/teachers-students/high-school-undergraduate-students.html", "/en/education-training/open-internships.html", "/en/education-training/faculty-professional-development-training-and-mentoring.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/graduate-program.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/postdoctoral-fellows-programs.html", null, "/en/about.html", "/en/about/about-the-hutch.html", "/en/about/about-the-hutch/patient-care-at-fred-hutch.html", "/en/about/about-the-hutch/accountability-impact.html", "/en/about/about-the-hutch/diversity-equity-inclusion.html", "/en/about/about-the-hutch/health-equity.html", "/en/about/about-the-hutch/history.html", "/en/about/about-the-hutch/honors-awards.html", "/en/about/about-the-hutch/institutional-partners-collaborations.html", "/en/about/about-the-hutch/leadership.html", "/en/about/about-the-hutch/mission-values.html", "/en/about/contact-us.html", "/en/about/contact-us/campus-map.html", "/en/about/contact-us/virtual-visit.html", "/en/about/contact-us/transportation.html", "/en/about/fred-hutch-locations.html", "/en/about/careers.html", "/en/events.html", "/en/about/for-media.html", "/en/news.html", null, "/en/ways-to-give.html", "/en/ways-to-give/give-now.html", "/en/ways-to-give/honor-a-loved-one.html", "/en/ways-to-give/give-through-your-will.html", "/en/ways-to-give/give-through-your-donor-advised-fund.html", "/en/ways-to-give/donate-cryptocurrency.html", "/en/ways-to-give/give-through-your-foundation.html", "/en/ways-to-give/make-a-corporate-gift.html", "/en/ways-to-give/create-an-endowment.html", "/en/ways-to-give/fundraise-for-fred-hutch.html", "https://www.obliteride.org", "/en/ways-to-give/fundraise-for-fred-hutch/create-your-own.html", "/en/ways-to-give/fundraise-for-fred-hutch/fundraiser-login.html", "/en/ways-to-give/philanthropy-events.html", "/en/ways-to-give/support-our-science.html", "/en/ways-to-give/support-our-science/greatest-need.html", "/en/ways-to-give/support-our-science/cancer-research.html", "/en/ways-to-give/support-our-science/data-science.html", "/en/ways-to-give/support-our-science/diversity-and-health-equity.html", "/en/ways-to-give/support-our-science/immunotherapy.html", "/en/ways-to-give/support-our-science/patient-support-services.html", "/en/ways-to-give/support-our-science/precision-oncology.html", "/en/ways-to-give/support-our-science/viruses-vaccines-infectious-diseases.html", "/en/ways-to-give/gift-clubs.html", "/en/ways-to-give/other-ways-to-give.html", "/en/ways-to-give/other-ways-to-give/give-monthly.html", "/en/ways-to-give/other-ways-to-give/donate-stock-bonds-mutual-funds.html", "/en/ways-to-give/other-ways-to-give/give-at-work.html", "/en/ways-to-give/other-ways-to-give/donate-vehicle-or-real-estate.html", "/en/ways-to-give/contact-us.html", "/en/util/redirect_stubs/donate.html", "/en/utility/search.html", "#0", "/en/patient-care.html", "/en/patient-care/patient-services.html", "/en/patient-care/patient-services.html", "/en/patient-care/patient-services/insurance-and-billing.html", "/en/patient-care/patient-services/medical-record-request.html", "/en/patient-care/patient-services/pharmacy.html", "/en/patient-care/patient-services/housing.html", "/en/patient-care/patient-services/amenities.html", "/en/patient-care/patient-services/interpreter-services.html", "/en/patient-care/patient-services/telehealth.html", "/en/patient-care/for-caregivers.html", "/en/patient-care/for-caregivers.html", "/en/patient-care/for-caregivers/resources.html", "/en/patient-care/services.html", "/en/patient-care/services.html", "/en/patient-care/services/cancer-rehabilitation.html", "/en/patient-care/services/child-life.html", "/en/patient-care/services/integrative-medicine.html", "/en/patient-care/services/nutrition.html", "/en/patient-care/services/oncoreproduction-clinic.html", "/en/patient-care/services/pain-clinic.html", "/en/patient-care/services/palliative-care.html", "/en/patient-care/services/patient-navigators.html", "/en/patient-care/services/physical-therapy.html", "/en/patient-care/services/psychiatry.html", "/en/patient-care/services/sexual-health.html", "/en/patient-care/services/social-work.html", "/en/patient-care/services/spiritual-health.html", "/en/patient-care/services/support-groups.html", "/en/patient-care/services/survivorship.html", "/en/patient-care/treatments.html", "/en/patient-care/treatments.html", "/en/patient-care/treatments/blood-marrow-transplant.html", "/en/patient-care/treatments/immunotherapy.html", "/en/patient-care/treatments/medical-oncology.html", "/en/patient-care/treatments/radiation-oncology.html", "/en/patient-care/treatments/surgical-oncology.html", "/en/patient-care/treatments/proton-therapy.html", "/en/patient-care/treatments/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy.html", "/en/patient-care/prevention.html", "/en/patient-care/prevention.html", "/en/patient-care/prevention/breast-cancer-screening.html", "/en/patient-care/prevention/colorectal-cancer-early-detection.html", "/en/patient-care/prevention/genetic-counseling-clinical-genetics.html", "/en/patient-care/prevention/lung-cancer-early-detection.html", "/en/patient-care/prevention/prostate-cancer-early-detection.html", "/en/patient-care/prevention/womens-wellness.html", "/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/about/fred-hutch-locations.html", "/en/patient-care/covid19.html", "/en/education-training/patient-education.html", "/en/about/contact-us/transportation.html", "/en/about/contact-us.html", "#0", "/en/diseases.html", "#0", "/en/research.html", "/en/research/research-areas.html", "/en/research/research-areas.html", "/en/research/research-areas/behavioral-research.html", "/en/research/research-areas/biostatistics.html", "/en/research/research-areas/cell-gene-therapy.html", "/en/research/research-areas/cell-biology.html", "/en/research/research-areas/data-science.html", "/en/research/research-areas/diagnostics-biomarkers.html", "/en/research/research-areas/disease-prevention.html", "/en/research/research-areas/epidemiology.html", "/en/research/research-areas/gene-regulation-expression.html", "/en/research/research-areas/genetics-and-genomics.html", "/en/research/research-areas/global-health.html", "/en/research/research-areas/health-economics.html", "/en/research/research-areas/hematopoietic-transplantation.html", "/en/research/research-areas/immunotherapy.html", "/en/research/research-areas/infectious-diseases.html", "/en/research/research-areas/microbiome.html", "/en/research/research-areas/survivorship.html", "/en/research/research-areas/vaccine-development.html", "/en/research/research-areas/virology.html", null, "/en/research/diseases.html", "/en/research/diseases.html", "/en/research/diseases/autoimmune-diseases.html", "/en/research/diseases/cancers.html", "/en/research/diseases/coronavirus.html", "/en/research/diseases/genetic-disorders.html", "/en/research/diseases/herpes.html", "/en/research/diseases/hiv-aids.html", "/en/research/divisions.html", "/en/research/divisions.html", "/en/research/divisions/basic-sciences-division.html", "/en/research/divisions/clinical-research-division.html", "/en/research/divisions/human-biology-division.html", "/en/research/divisions/public-health-sciences-division.html", "/en/research/divisions/vaccine-infectious-disease-division.html", "/en/research/clinical-trials.html", "/en/research/clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials/health-insurance.html", "/en/research/clinical-trials/guide-clinical-trials/deciding-to-participate.html", "/en/research/covid-19-clinical-research-center.html", "/en/research/patient-treatment-support/long-term-follow-up.html", "/en/research/patient-treatment-support/survivorship-program.html", "https://www.cookforyourlife.org/", "/en/faculty-lab-directory.html", "/en/education-training.html", "/en/research/institutes-networks-ircs.html", "/en/research/institutes-networks-ircs.html", "/en/research/institutes-networks-ircs/ocoe.html", "/en/projects.html", "/en/research/scientific-publications.html", "/en/research/shared-resources.html", "/en/investors.html", "#0", "/en/education-training.html", "/en/education-training/patient-education.html", "/en/education-training/patient-education.html", "/en/education-training/patient-education/resource-center.html", "/en/education-training/patient-education/courses.html", "/en/education-training/patient-education/videos.html", "/en/education-training/health-care-professionals.html", "/en/education-training/health-care-professionals.html", "/en/education-training/health-care-professionals/provider-professional-development.html", "/en/education-training/health-care-professionals/nursing-professional-development.html", "/en/education-training/teachers-students.html", "/en/education-training/teachers-students.html", "/en/education-training/teachers-students/science-education-partnership.html", "/en/education-training/teachers-students/high-school-undergraduate-students.html", "/en/education-training/open-internships.html", "/en/education-training/faculty-professional-development-training-and-mentoring.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/graduate-program.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/postdoctoral-fellows-programs.html", "#0", null, "/en/about.html", "/en/about/about-the-hutch.html", "/en/about/about-the-hutch.html", "/en/about/about-the-hutch/patient-care-at-fred-hutch.html", "/en/about/about-the-hutch/accountability-impact.html", "/en/about/about-the-hutch/diversity-equity-inclusion.html", "/en/about/about-the-hutch/health-equity.html", "/en/about/about-the-hutch/history.html", "/en/about/about-the-hutch/honors-awards.html", "/en/about/about-the-hutch/institutional-partners-collaborations.html", "/en/about/about-the-hutch/leadership.html", "/en/about/about-the-hutch/mission-values.html", "/en/about/contact-us.html", "/en/about/contact-us.html", "/en/about/contact-us/campus-map.html", "/en/about/contact-us/virtual-visit.html", "/en/about/contact-us/transportation.html", "/en/about/fred-hutch-locations.html", "/en/about/careers.html", "/en/events.html", "/en/about/for-media.html", "/en/news.html", "#0", "/en/ways-to-give.html", "/en/ways-to-give/give-now.html", "/en/ways-to-give/honor-a-loved-one.html", "/en/ways-to-give/give-through-your-will.html", "/en/ways-to-give/give-through-your-donor-advised-fund.html", "/en/ways-to-give/donate-cryptocurrency.html", "/en/ways-to-give/give-through-your-foundation.html", "/en/ways-to-give/make-a-corporate-gift.html", "/en/ways-to-give/create-an-endowment.html", "/en/ways-to-give/fundraise-for-fred-hutch.html", "/en/ways-to-give/fundraise-for-fred-hutch.html", "https://www.obliteride.org", "/en/ways-to-give/fundraise-for-fred-hutch/create-your-own.html", "/en/ways-to-give/fundraise-for-fred-hutch/fundraiser-login.html", "/en/ways-to-give/philanthropy-events.html", "/en/ways-to-give/support-our-science.html", "/en/ways-to-give/support-our-science.html", "/en/ways-to-give/support-our-science/greatest-need.html", "/en/ways-to-give/support-our-science/cancer-research.html", "/en/ways-to-give/support-our-science/data-science.html", "/en/ways-to-give/support-our-science/diversity-and-health-equity.html", "/en/ways-to-give/support-our-science/immunotherapy.html", "/en/ways-to-give/support-our-science/patient-support-services.html", "/en/ways-to-give/support-our-science/precision-oncology.html", "/en/ways-to-give/support-our-science/viruses-vaccines-infectious-diseases.html", "/en/ways-to-give/gift-clubs.html", "/en/ways-to-give/other-ways-to-give.html", "/en/ways-to-give/other-ways-to-give.html", "/en/ways-to-give/other-ways-to-give/give-monthly.html", "/en/ways-to-give/other-ways-to-give/donate-stock-bonds-mutual-funds.html", "/en/ways-to-give/other-ways-to-give/give-at-work.html", "/en/ways-to-give/other-ways-to-give/donate-vehicle-or-real-estate.html", "/en/ways-to-give/contact-us.html", "/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/patient-care/for-physicians.html", "/en/about/careers.html", "/en/about/fred-hutch-locations.html", "/en/about/contact-us.html", "/en/util/redirect_stubs/donate.html", "/en/news.html", "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html&title=%C2%BFLa+cura+del+herpes%3F+Hay+avances+que+reportar+&summary=Las+t%C3%A9cnicas+mejoradas+de+terapia+g%C3%A9nica+eliminan+hasta+el+95%25+del+virus+del+herpes%2C+inactivo+en+ratones.+%C2%BFHabr%C3%A1+estudios+cl%C3%ADnicos+con+personas%3F+Faltan+por+lo+menos+tres+a%C3%B1os.+El+Dr.+Keith+Jerome+espera+que+esta+investigaci%C3%B3n+nos+motive+a+pensar+en+la+posibilidad+de+la+cura+del+virus.+&source=Fred+Hutch", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html&via=fredhutch", "mailto:?subject=www.fredhutch.org%C2%BFLa%20cura%20del%20herpes%3F%20Hay%20avances%20que%20reportar%20&body=From%20Fred%20Hutchinson%20Cancer%20Center%3A%0A%0A%C2%BFLa%20cura%20del%20herpes%3F%20Hay%20avances%20que%20reportar%20%0A%0ALos%20estudios%20con%20ratones%20muestran%20que%20la%20terapia%20g%C3%A9nica%20puede%20reducir%20much%C3%ADsimo%20las%20infecciones%20inactivas%0A%0Ahttps%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html%0A%0Awww.fredhutch.org", "/en/news.html?author=web-writers:russell-sabin", "/en/news/center-news/2020/08/herpes-simplex-gene-therapy.html", "/en/faculty-lab-directory/jerome-keith.html", "/en/research/divisions/vaccine-infectious-disease-division/faculty-labs/vidd-staff-scientists-physicians/aubert-martine.html", "/en/news/center-news/2016/09/can-gene-editing-cure-herpes.html", "http://dx.doi.org/10.1038/s41467-020-17936-5", "https://www.who.int/es/news-room/fact-sheets/detail/herpes-simplex-virus", "https://medlineplus.gov/spanish/druginfo/meds/a681045-es.html", "https://www.cdc.gov/nchs/products/databriefs/db304.htm", "https://secure.fredhutch.org/site/SPageServer?pagename=adf_evergreen&experience=evergreen&s_src=WEB&s_subsrc=aeuio24&fh_element=press_release&creator=fh&version=control&team=philanthropy", "/en/faculty-lab-directory/stoddard-barry.html", "https://www.fredhutch.org/en/research/diseases/herpes.html", "mailto:HSV@fredhutch.org", "mailto:communications@fredhutch.org", "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html&title=%C2%BFLa+cura+del+herpes%3F+Hay+avances+que+reportar+&summary=Las+t%C3%A9cnicas+mejoradas+de+terapia+g%C3%A9nica+eliminan+hasta+el+95%25+del+virus+del+herpes%2C+inactivo+en+ratones.+%C2%BFHabr%C3%A1+estudios+cl%C3%ADnicos+con+personas%3F+Faltan+por+lo+menos+tres+a%C3%B1os.+El+Dr.+Keith+Jerome+espera+que+esta+investigaci%C3%B3n+nos+motive+a+pensar+en+la+posibilidad+de+la+cura+del+virus.+&source=Fred+Hutch", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html&via=fredhutch", "mailto:?subject=www.fredhutch.org%C2%BFLa%20cura%20del%20herpes%3F%20Hay%20avances%20que%20reportar%20&body=From%20Fred%20Hutchinson%20Cancer%20Center%3A%0A%0A%C2%BFLa%20cura%20del%20herpes%3F%20Hay%20avances%20que%20reportar%20%0A%0ALos%20estudios%20con%20ratones%20muestran%20que%20la%20terapia%20g%C3%A9nica%20puede%20reducir%20much%C3%ADsimo%20las%20infecciones%20inactivas%0A%0Ahttps%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fcenter-news%2F2020%2F08%2Fherpes-simple-terapia-genica.html%0A%0Awww.fredhutch.org", "https://www.fredhutch.org/en/news.html", "https://www.fredhutch.org/en/news/center-news/2020/06/verdad-mentira-resfriado-gripe.html", "https://www.fredhutch.org/en/news/center-news/2020/06/verdad-mentira-resfriado-gripe.html", "https://www.fredhutch.org/en/news/center-news/2020/06/que-no-decir-a-un-paciente-con-cancer.html", "https://www.fredhutch.org/en/news/center-news/2020/06/que-no-decir-a-un-paciente-con-cancer.html", "https://www.fredhutch.org/en/news/center-news/2019/08/beti-thompson-campeona-ciencia-justicia-social.html", "https://www.fredhutch.org/en/news/center-news/2019/08/beti-thompson-campeona-ciencia-justicia-social.html", "/en/news.related.Wyd3ZWItZmFjdWx0eTpKL0tlaXRoIEplcm9tZSdd.html", "/en/news.related.Wyd3ZWItZGlzZWFzZTpvdGhlci1kaXNlYXNlcy9vcHBvcnR1bmlzdGljLWluZmVjdGlvbnMvaGVycGVzdmlydXMtaW5mZWN0aW9ucydd.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0gvaGVycGVzJ10=.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0gvSGVycGVzIFNpbXBsZXggVmlydXMtMidd.html", "/en/news.related.WydkaXZpc2lvbnM6dmlkZCdd.html", "/en/news.related.Wyd3ZWItZmFjdWx0eTpTL0JhcnJ5IFN0b2RkYXJkJ10=.html", "/en/news.related.WydkaXZpc2lvbnM6YmFzaWMtc2NpZW5jZXMnXQ==.html", "/en/news.related.WydyZXNlYXJjaC1hcmVhczpjZWxsLWdlbmUtdGhlcmFweSdd.html", "/en/news.related.Wyd3ZWItZmFjdWx0eTpBL01hcnRpbmUgQXViZXJ0J10=.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0cvZ2VuZS1lZGl0aW5nJ10=.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0MvY3Jpc3ByJ10=.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0gvaGVycGVzdmlydXMnXQ==.html", "/en/about/for-media.html", "/en/news/releases.html", "/en/news/media-coverage.html", "/en/about/about-the-hutch.html", "/en.html", "/en/news.html", "/en/news/center-news/2020/08.html", "/en.html", "/en/about/contact-us.html", "/en/about/about-the-hutch/accountability-impact.html", "/en/about/contact-us/employee.html", "http://engage.fredhutch.org/site/Survey?SURVEY_ID=1360&ACTION_REQUIRED=URI_ACTION_USER_REQUESTS", "/en/util/terms-privacy.html", "/en/util/conflict-of-interest.html", "/en/util/patient-policies.html#public-policy", "/en/util/patient-policies.html#public-care-policy", "/en/util/patient-policies.html#disclaimer", "/en/util/patient-policies.html#notice-nondiscrimination-accessibility-a", "https://www.facebook.com/HutchinsonCenter", "https://twitter.com/fredhutch", "https://www.linkedin.com/company/fred-hutchinson-cancer-research-center/", "https://www.youtube.com/channel/UCnWBh22UKMHF4VRKdsQvZqg/featured", "https://www.instagram.com/FredHutch/", "tel:206-667-5000", "/en/about/contact-us.html", "https://www.cancer.gov", "https://www.nccn.org", "http://www.aahrpp.org", "https://www.forbes.com/best-midsize-employers/list/", "https://www.guidestar.org/profile/shared/4a568da4-8981-4bd6-b3fe-86c28f77f341", "https://www.eeoc.gov/sites/default/files/2022-10/EEOC_KnowYourRights_screen_reader_10_20.pdf", "#top"]}